• Explore /
  • Poster
  • / CT and PET radiomic features associated with major pathologic response to neoadjuvant immunotherapy in early-stage non-small cell lung cancer (NSCLC).

CT and PET radiomic features associated with major pathologic response to neoadjuvant immunotherapy in early-stage non-small cell lung cancer (NSCLC).

Abstract Poster

Authors

null

Erica C. Nakajima

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

Erica C. Nakajima , Jeffrey P. Leal , Wei Fu , Hao Wang , Jamie E. Chaft , Matthew David Hellmann , Martin Pomper , Patrick M. Forde

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Local-Regional Non–Small Cell Lung Cancer

Citation

J Clin Oncol 38: 2020 (suppl; abstr 9031)

DOI

10.1200/JCO.2020.38.15_suppl.9031

Abstract #

9031

Poster Bd #

224

Abstract Disclosures

Funded by Conquer Cancer

Similar Posters

First Author: Antonio D'Alessio

First Author: Sabine Breukers

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Assessment of complete pathologic response after neoadjuvant immunotherapy for MSI-H gastrointestinal cancers.

Assessment of complete pathologic response after neoadjuvant immunotherapy for MSI-H gastrointestinal cancers.

First Author: Kruti Bhagirath Vora

Poster

2022 ASCO Annual Meeting

Neoadjuvant nivolumab in early-stage non–small cell lung cancer (NSCLC): Five-year outcomes.

Neoadjuvant nivolumab in early-stage non–small cell lung cancer (NSCLC): Five-year outcomes.

First Author: Samuel Rosner